Exelixis Historical Income Statement

EXEL Stock

USD 35.61 0.78 2.24%

Historical analysis of Exelixis income statement accounts such as Gross Profit of 1.8 B or Other Operating Expenses of 1.7 B can show how well Exelixis performed in making a profits. Evaluating Exelixis income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Exelixis's future profits or losses.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Exelixis latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Exelixis is a good buy for the upcoming year.

Net Income Gross Profit

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Exelixis. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

For more information on how to buy Exelixis Stock please use our How to buy in Exelixis Stock guide.

About Exelixis Income Statement Analysis

Exelixis Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Exelixis shareholders. The income statement also shows Exelixis investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Exelixis Income Statement Chart

At this time, Exelixis' EBIT is quite stable compared to the past year. Research Development is expected to rise to about 1.1 B this year, although the value of Net Income From Continuing Ops will most likely fall to about 81 M.

Total Revenue Gross Profit Other Operating Expenses Ebit Research Development Total Other Income Expense Net

Total Revenue

Total revenue comprises all receipts Exelixis generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Exelixis minus its cost of goods sold. It is profit before Exelixis operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Exelixis. It is also known as Exelixis overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Most accounts from Exelixis' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Exelixis current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Exelixis. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

For more information on how to buy Exelixis Stock please use our How to buy in Exelixis Stock guide.At this time, Exelixis' EBIT is quite stable compared to the past year. Research Development is expected to rise to about 1.1 B this year, although the value of Net Income From Continuing Ops will most likely fall to about 81 M.

	2021	2022	2023	2024 (projected)
Gross Profit	1.4B	1.6B	1.8B	1.8B
Total Revenue	1.4B	1.6B	1.8B	1.9B

Gross Profit Total Revenue

Exelixis income statement Correlations

	Interest Expense	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Research Development	Ebitda	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Depreciation And Amortization	Cost Of Revenue	Income Tax Expense	Selling General Administrative	Net Income From Continuing Ops	Non Recurring	Non Operating Income Net Other	Net Interest Income	Tax Provision	Interest Income	Selling And Marketing Expenses	Reconciled Depreciation
Interest Expense		0.27	0.27	0.45	-0.38	-0.38	0.5	-0.35	0.46	-0.28	0.33	-0.35	0.48	0.04	0.3	0.34	-0.5	-0.14	0.25	0.57	0.24	0.58	0.32	0.36
Total Revenue	0.27		1.0	0.97	0.69	0.68	0.95	0.71	0.97	0.77	0.87	0.63	0.92	0.13	0.25	0.99	0.5	-0.6	0.28	0.82	0.22	0.82	0.93	0.93
Gross Profit	0.27	1.0		0.97	0.69	0.69	0.95	0.71	0.97	0.77	0.87	0.64	0.92	0.13	0.25	0.99	0.5	-0.6	0.28	0.82	0.22	0.82	0.93	0.93
Other Operating Expenses	0.45	0.97	0.97		0.49	0.48	1.0	0.52	1.0	0.59	0.86	0.43	0.95	0.12	0.37	0.98	0.28	-0.55	0.33	0.87	0.33	0.87	0.94	0.93
Operating Income	-0.38	0.69	0.69	0.49		1.0	0.42	1.0	0.48	0.99	0.54	0.97	0.46	0.1	-0.18	0.61	0.95	-0.51	0.02	0.36	-0.18	0.36	0.52	0.55
Ebit	-0.38	0.68	0.69	0.48	1.0		0.42	1.0	0.48	0.99	0.54	0.97	0.46	0.11	-0.19	0.6	0.95	-0.5	0.02	0.35	-0.19	0.35	0.52	0.55
Research Development	0.5	0.95	0.95	1.0	0.42	0.42		0.45	1.0	0.53	0.86	0.36	0.96	0.16	0.4	0.96	0.21	-0.49	0.34	0.87	0.36	0.87	0.93	0.92
Ebitda	-0.35	0.71	0.71	0.52	1.0	1.0	0.45		0.51	0.99	0.56	0.97	0.49	0.12	-0.17	0.63	0.94	-0.51	0.04	0.38	-0.18	0.38	0.55	0.58
Total Operating Expenses	0.46	0.97	0.97	1.0	0.48	0.48	1.0	0.51		0.58	0.86	0.43	0.95	0.12	0.37	0.98	0.28	-0.55	0.33	0.87	0.33	0.87	0.94	0.93
Income Before Tax	-0.28	0.77	0.77	0.59	0.99	0.99	0.53	0.99	0.58		0.65	0.96	0.58	0.12	-0.12	0.69	0.91	-0.51	0.05	0.48	-0.13	0.48	0.6	0.64
Total Other Income Expense Net	0.33	0.87	0.87	0.86	0.54	0.54	0.86	0.56	0.86	0.65		0.53	0.92	0.19	0.2	0.84	0.39	-0.39	0.23	0.92	0.17	0.92	0.76	0.81
Net Income	-0.35	0.63	0.64	0.43	0.97	0.97	0.36	0.97	0.43	0.96	0.53		0.44	0.08	-0.4	0.55	0.98	-0.46	0.04	0.36	-0.41	0.36	0.45	0.51
Depreciation And Amortization	0.48	0.92	0.92	0.95	0.46	0.46	0.96	0.49	0.95	0.58	0.92	0.44		0.26	0.29	0.91	0.3	-0.34	0.21	0.91	0.25	0.9	0.89	0.9
Cost Of Revenue	0.04	0.13	0.13	0.12	0.1	0.11	0.16	0.12	0.12	0.12	0.19	0.08	0.26		0.09	0.04	0.03	0.43	-0.13	0.13	0.1	0.12	0.12	0.12
Income Tax Expense	0.3	0.25	0.25	0.37	-0.18	-0.19	0.4	-0.17	0.37	-0.12	0.2	-0.4	0.29	0.09		0.3	-0.46	-0.06	-0.04	0.28	0.99	0.29	0.34	0.26
Selling General Administrative	0.34	0.99	0.99	0.98	0.61	0.6	0.96	0.63	0.98	0.69	0.84	0.55	0.91	0.04	0.3		0.41	-0.65	0.31	0.82	0.26	0.82	0.94	0.93
Net Income From Continuing Ops	-0.5	0.5	0.5	0.28	0.95	0.95	0.21	0.94	0.28	0.91	0.39	0.98	0.3	0.03	-0.46	0.41		-0.38	-0.04	0.18	-0.45	0.18	0.35	0.39
Non Recurring	-0.14	-0.6	-0.6	-0.55	-0.51	-0.5	-0.49	-0.51	-0.55	-0.51	-0.39	-0.46	-0.34	0.43	-0.06	-0.65	-0.38		-0.4	-0.38	-0.03	-0.4	-0.52	-0.52
Non Operating Income Net Other	0.25	0.28	0.28	0.33	0.02	0.02	0.34	0.04	0.33	0.05	0.23	0.04	0.21	-0.13	-0.04	0.31	-0.04	-0.4		0.22	0.0	0.23	0.31	0.31
Net Interest Income	0.57	0.82	0.82	0.87	0.36	0.35	0.87	0.38	0.87	0.48	0.92	0.36	0.91	0.13	0.28	0.82	0.18	-0.38	0.22		0.22	1.0	0.72	0.79
Tax Provision	0.24	0.22	0.22	0.33	-0.18	-0.19	0.36	-0.18	0.33	-0.13	0.17	-0.41	0.25	0.1	0.99	0.26	-0.45	-0.03	0.0	0.22		0.23	0.32	0.23
Interest Income	0.58	0.82	0.82	0.87	0.36	0.35	0.87	0.38	0.87	0.48	0.92	0.36	0.9	0.12	0.29	0.82	0.18	-0.4	0.23	1.0	0.23		0.71	0.78
Selling And Marketing Expenses	0.32	0.93	0.93	0.94	0.52	0.52	0.93	0.55	0.94	0.6	0.76	0.45	0.89	0.12	0.34	0.94	0.35	-0.52	0.31	0.72	0.32	0.71		0.98
Reconciled Depreciation	0.36	0.93	0.93	0.93	0.55	0.55	0.92	0.58	0.93	0.64	0.81	0.51	0.9	0.12	0.26	0.93	0.39	-0.52	0.31	0.79	0.23	0.78	0.98

Click cells to compare fundamentals

Exelixis Account Relationship Matchups

Exelixis income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Revenue	967.8M	987.5M	1.4B	1.6B	1.8B	1.9B
Gross Profit	934.7M	951.3M	1.4B	1.6B	1.8B	1.8B
Other Operating Expenses	598.3M	877.5M	1.1B	1.4B	1.7B	1.7B
Operating Income	369.5M	110.1M	286.7M	201.5M	170.9M	179.4M
Ebit	369.5M	110.1M	286.7M	201.5M	170.9M	179.4M
Research Development	337.0M	547.9M	693.7M	891.8M	1.0B	1.1B
Ebitda	377.8M	119.2M	300.3M	222.4M	196.6M	206.4M
Total Operating Expenses	565.2M	841.2M	1.1B	1.4B	1.6B	1.7B
Income Before Tax	398.1M	130.8M	294.2M	234.4M	257.5M	270.4M
Total Other Income Expense Net	28.6M	20.8M	7.5M	32.9M	86.6M	91.0M
Net Income	321.0M	111.8M	231.1M	182.3M	207.8M	218.2M
Depreciation And Amortization	8.3M	9.1M	13.6M	20.9M	25.7M	27.0M
Cost Of Revenue	33.1M	36.3M	52.9M	57.9M	72.5M	55.5M
Income Tax Expense	77.1M	19.1M	63.1M	52.1M	49.8M	52.2M
Selling General Administrative	228.2M	293.4M	401.7M	459.9M	502.7M	527.8M
Net Income From Continuing Ops	321.0M	111.8M	231.1M	182.3M	92.1M	81.0M
Non Operating Income Net Other	680K	912K	(184K)	(197K)	(226.6K)	(237.9K)
Net Income Applicable To Common Shares	321.0M	111.8M	231.1M	182.3M	209.6M	220.1M
Net Interest Income	28.0M	19.9M	7.7M	33.1M	82.1M	86.3M
Tax Provision	77.1M	19.1M	63.1M	52.1M	31.0M	32.5M
Interest Income	28.0M	19.9M	7.7M	33.1M	82.1M	86.3M
Selling And Marketing Expenses	17.9M	25.1M	31.8M	41.6M	40M	28.3M
Reconciled Depreciation	8.3M	9.1M	13.6M	20.9M	25.1M	13.5M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Exelixis is a strong investment it is important to analyze Exelixis' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Exelixis' future performance. For an informed investment choice regarding Exelixis Stock, refer to the following important reports:

How To Invest In Exelixis

Details

Is Exelixis Stock a good investment?

Details

What is Exelixis' Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

For more information on how to buy Exelixis Stock please use our How to buy in Exelixis Stock guide.

You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Exelixis. If investors know Exelixis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Exelixis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

121.699

Earnings Share

1.55

Revenue Per Share

7.032

Quarterly Revenue Growth

0.143

Return On Assets

0.1281

The market value of Exelixis is measured differently than its book value, which is the value of Exelixis that is recorded on the company's balance sheet. Investors also form their own opinion of Exelixis' value that differs from its market value or its book value, called intrinsic value, which is Exelixis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Exelixis' market value can be influenced by many factors that don't directly affect Exelixis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Exelixis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Exelixis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Exelixis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Exelixis Historical Income Statement

About Exelixis Income Statement Analysis

Exelixis Income Statement Chart

Total Revenue

Gross Profit

Other Operating Expenses

Exelixis income statement Correlations

Exelixis Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Exelixis income statement Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Gross Profit	+ 1.0	Total Revenue
Research Development	+ 1.0	Other Operating Expenses
Total Operating Expenses	+ 1.0	Other Operating Expenses
Ebit	+ 1.0	Operating Income
Ebitda	+ 1.0	Operating Income
Ebitda	+ 1.0	Ebit

Non Recurring	- 0.65	Selling General Administrative
Non Recurring	- 0.6	Gross Profit
Non Recurring	- 0.6	Total Revenue
Non Recurring	- 0.55	Total Operating Expenses
Non Recurring	- 0.55	Other Operating Expenses
Reconciled Depreciation	- 0.52	Non Recurring